UBS OCONNOR LLC - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 94 filers reported holding THERAPEUTICSMD INC in Q1 2015. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q2 2016$33,000,000
-97.4%
20,900
-89.6%
0.00%
-95.7%
Q1 2016$1,280,000,000
+884.6%
200,000
+1500.0%
0.02%
+1050.0%
Q4 2015$130,000,000
-48.2%
12,500
-80.4%
0.00%
-60.0%
Q3 2015$251,000,000
-89.0%
63,780
-78.1%
0.01%
-87.5%
Q2 2015$2,287,000,000
+56.3%
291,000
+20.3%
0.04%
+29.0%
Q1 2015$1,463,000,000
+31.6%
241,838
-3.3%
0.03%
+63.2%
Q4 2014$1,112,000,000
+6.5%
250,000
+11.1%
0.02%
+5.6%
Q3 2014$1,044,000,000
+5.0%
225,0000.0%0.02%
-10.0%
Q2 2014$994,000,000
-37.0%
225,000
-10.0%
0.02%
-33.3%
Q1 2014$1,578,000,000
+438.6%
250,000
+150.0%
0.03%
+400.0%
Q3 2013$293,000,000100,0000.01%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,460,225$24,914,0004.95%
Newtyn Management, LLC 1,800,000$12,960,0001.95%
1492 Capital Management LLC 222,485$1,602,0001.25%
SANDERS MORRIS HARRIS LLC 967,200$6,964,0001.18%
MORGENS WATERFALL VINTIADIS & CO INC 180,000$1,296,0001.15%
SPHERA FUNDS MANAGEMENT LTD. 580,000$4,176,0000.82%
Rock Springs Capital Management LP 1,600,000$11,520,0000.66%
STONERIDGE INVESTMENT PARTNERS LLC 467,425$3,365,0000.45%
Capital Impact Advisors, LLC 157,411$1,133,0000.45%
GILDER GAGNON HOWE & CO LLC 3,059,690$22,030,0000.37%
View complete list of THERAPEUTICSMD INC shareholders